"The providers at Nashville Oncology Associates are known for their excellence in oncology practice. By creating and nurturing an atmosphere of trust and compassion, the practice always puts the patient first. Nashville Oncology Associates offer comprehensive oncology services using advanced diagnostic methods, therapeutic options, and leading edge treatments in a beautifully remodeled facility."

During the past decade, Nashville Oncology Associates PC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 15 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nashville Oncology Associates PC" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Pierian Biosciences" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "ETOP IBCSG Partners Foundation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nashville Oncology Associates PC" #1 collaborator was "Cancer and Leukemia Group B" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Nashville Oncology Associates PC" are "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (3 trials), "Breast Adenocarcinoma" (2 trials), "Breast Cancer" (2 trials) and "Male Breast Carcinoma" (2 trials). Many other conditions were trialed in "Nashville Oncology Associates PC" in a lesser frequency.

Most popular intervention types in "Nashville Oncology Associates PC" are "Drug" (16 trials), "Other" (14 trials), "Biological" (9 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Bevacizumab" (6 trials), "Quality-of-Life Assessment" (5 trials), "Paclitaxel" (4 trials) and "Doxorubicin Hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Nashville Oncology Associates PC" are 14 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Nashville Oncology Associates PC". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Nashville Oncology Associates PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nashville Oncology Associates PC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".